According to Diabetes UK 4.5 million people in the UK have diabetes with 90% being type 2 diabetes. A further 1.1 million people are estimated to have diabetes but are not yet diagnosed. Diabetes is a big problem in the UK, and a large healthcare and treatment industry has built up around it. Products from companies like Abbott, Acensia, AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Lilly, GlaxoSmithKline, LifeScan, Merck, Novo Nordisk, Pfizer, Roche, Sanofi and Takeda help many people living with diabetes in the UK to have a better quality of life.
At CREATION we wanted to help these organisations better understand the needs of the UK healthcare professionals (HCPs) involved in helping diabetes patients. We conducted a CREATION Deep Dive study examining HCP conversations on social media throughout 2016 in order to learn what HCPs were saying around products, new treatments, clinical trial data, their thoughts around drug pricing and to identify their key areas of need.
Listening to the organic unprompted conversations HCPs are having on social media is helpful when planning any engagement strategies either online or offline. It allows you to understand what is truly important to them and create resources that fulfil their needs. Our aim is that this report will add value to the diabetes community by strengthening the relationship between HCPs and pharmaceutical companies.
If you would like more information on this report please contact Katie Barden on firstname.lastname@example.org or +44 7540 308 370
The header image was sourced from Flickr user ILO in Asia and the Pacific, under creative commons licence.